Centro Cardiologico Monzino, IRCCS, Milano, Italy.
Pulmonary Services Laboratory, UC Davis Medical Center, Sacramento, California, United States.
Respir Physiol Neurobiol. 2021 Aug;290:103679. doi: 10.1016/j.resp.2021.103679. Epub 2021 May 4.
Alveolar-capillary membrane diffusing capacity for carbon monoxide (DMCO) and pulmonary capillary volume (Vcap) can be estimated by the multi-step Roughton and Foster (RF, original method from 1957) or the single-step NO-CO double diffusion technique (developed in the 1980s). The latter method implies inherent assumptions. We sought to determine which combination of the alveolar membrane diffusing capacity for nitric oxide (DMNO) to DMCO ratio, an specific conductance of the blood for NO (θ) and CO (θ) gave the lowest week-to-week variability in patients with heart failure.
44 heart failure patients underwent DMCO and Vcap measurements on three occasions over a ten-week period using both RF and double dilution NO-CO techniques.
When using the double diffusing method and applying θ = infinity, the smallest week-to-week coefficient of variation for DMCO was 10 %. Conversely, the RF method derived DMCO had a much greater week-to-week variability (2x higher coefficient of variation) than the DMCO derived via the NO-CO double dilution technique. The DMCO derived from the double diffusion technique most closely matched the DMCO from the RF method when θ = infinity and DMCO = DLNO/2.42. The Vcap measured week-to-week was unreliable regardless of the method or constants used.
In heart failure patients, the week-to-week DMCO variability was lowest when using the single-step NO-CO technique. DMCO obtained from double diffusion most closely matched the RF DMCO when DMCO/2.42 and θ = infinity. Vcap estimation was unreliable with either method.
一氧化碳通过肺泡毛细血管膜的扩散能力(DMCO)和肺毛细血管容积(Vcap)可以通过多步罗顿和福斯特(RF,1957 年的原始方法)或单步 NO-CO 双扩散技术(20 世纪 80 年代开发)来估计。后一种方法隐含着一些假设。我们试图确定一氧化氮通过肺泡膜的扩散能力(DMNO)与 DMCO 的比值、NO(θ)和 CO(θ)的血液特定传导率的哪种组合在心力衰竭患者中具有最低的每周变异性。
44 例心力衰竭患者在 10 周内通过 RF 和双稀释 NO-CO 技术进行了三次 DMCO 和 Vcap 测量。
当使用双扩散方法并应用θ=无穷大时,DMCO 的每周变异系数最小为 10%。相反,RF 方法衍生的 DMCO 的每周变异性(变异系数高 2 倍)大于通过 NO-CO 双稀释技术衍生的 DMCO。当θ=无穷大且 DMCO=DLNO/2.42 时,双扩散技术衍生的 DMCO 最接近 RF 方法衍生的 DMCO。无论使用哪种方法或常数,每周测量的 Vcap 都不可靠。
在心力衰竭患者中,使用单步 NO-CO 技术时,DMCO 的每周变异性最低。当 DMCO/2.42 和θ=无穷大时,双扩散法获得的 DMCO 与 RF DMCO 最匹配。两种方法的 Vcap 估计均不可靠。